Royalty Report: Device, Medical, Surgical – Collection: 163887

$150.00

Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 14

Description

This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 14

Primary Industries

  • Device
  • Medical
  • Surgical
  • Diagnostic
  • cardiac
  • Catheter
  • Delivery
  • Software
  • Medical Info
  • Drugs
  • Biotechnology

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 163887

License Grant
Assignor sells, assigns, conveys, transfers and delivers to Assignee, its successors and permitted assigns, the Spot Catheter Patents and the Spot Catheter Technology and the Linear Catheter Patents and the Linear Catheter Technology to be used only in the Field of Use.
License Property
Assignor is in the business of developing implantable cardiac defibrillators and electrophysiology catheters. The IP includes patents and U.S. Patent Applications, Serial Nos. 08/496,947 and 09/073,651 and corresponding foreign patents.
Field of Use
The Field of Use shall mean the radio frequency (RF) cardiac ablation therapy field.  This agreement pertains to the medical industry.

IPSCIO Record ID: 5091

License Grant
The Licensee also has the exclusive right to distribute and manufacture the Company’s Trio/Ensemble diagnostic catheters in all territories of the world except southern Europe and Japan.
License Property
The Trio/Ensemble catheters are used for electrophysiological diagnostic mapping of supraventricular tachycardia (SVT), a congenital, rapid heart rhythm that originates above the ventricles in the heart. Using the Trio/Ensemble diagnostic catheters, the electrophysiologist is able to place three catheters through a single patient introduction site rather than having to use three separate introduction sites.  In this way, the Trio/Ensemble provides the electrophysiologist with an overall tool to assess electrical conduction between the atria and the ventricle. Once the SVT is mapped, it can readily be treated using standard radio frequency (RF) catheter ablation techniques to neutralize the heart tissue responsible for the abnormal heart rhythm.
Field of Use
The rights are granted to be used for electrophysiological diagnostic mapping of supraventricular tachycardia (SVT), a congenital, rapid heart rhythm that originates above the ventricles in the heart.

IPSCIO Record ID: 283410

License Grant
The Licensor, a nonprofit American academic medical center,  grants to Company the following (a) an exclusive license with the right to sublicense, within the Field and Territory, under the Patent Rights to make, have made, use, offer for sale, sell, and import Licensed Products; and (b) a nonexclusive license, with the right to sublicense, within the Field and Territory, to use the Know-How to develop, make, have made, use, offer for sale, sell, and import Licensed Products.
License Property
Patent Rights shall mean U.S. patent number 8,538,501, and any re-examinations and re-issues thereof, as well as extensions and supplementary protection certificates and any foreign counterpart of any of the foregoing.

8,538,501 – Mapping and ablation catheter system

Licensed Product shall mean any product, process, or service which (a) the manufacture, use, sale, offer for sale or importation of which infringes an issued claim of the Patent Rights, or that would infringe but for the exception in 35 U.S.C. §271(e)(1), or similar exception in the United States or other countries; or (b) the development, manufacture, use, sale, offer for sale or importation of which incorporates, uses, was derived from, identified by, validated, or developed in whole or in part using the Know-How.

Field of Use
Field shall mean a mapping and ablation catheter system.
Pure EP is a computerized system designed to acquire, digitize, measure, display and store electrocardiographic and intracardiac signals for patients undergoing electrophysiology procedures.
The product sets out to assist electrophysiologists with decision-making during EP procedures in patients with abnormal heart rates and rhythms.

IPSCIO Record ID: 310350

License Grant
Licensor grants a worldwide, non-transferable, and non-sub licensable license to make, have made, use and sell Licensed Products in the Field of Use.  The licensed granted shall be co-exclusive, meaning that Licensor or any Affiliate of Licensor shall also have the worldwide right to make, have made, use, sell or otherwise commercialize and exploit the Licensed Technology in the Field of Use, provided that Licensor shall not grant any licenses to the Licensed Technology in the Field of Use during the term of this Agreement.
License Property
Licensor has developed certain technology related to catheter navigation and mapping.

Licensor is a medical device company, with products including cardiac devices, cranial and spine robotics, insulin pumps, surgical tools, and patient monitoring systems.

This agreement is for the technology, patent and applications are for Catheter Mapping System and Application, including, specifically, U.S Patent No 5,697,377, and all trade secrets and know-how owned by Licensor prior to the date of this Agreement which relate specifically and directly to 3-D electrode localization devices and techniques as disclosed in the patents or patent applications, including but not necessarily limited to software developed specifically to practice the inventions disclosed in the patents included in the Licensed Technology, and new patents arising out of patent applications filed, or inventions reduced to practice and relate specifically and directly to 3-D electrode localization devices and techniques.

Field of Use
The Field of Use shall mean electrophysiological intracardiac mapping applications for the treatment of cardiac arrhythmias.

Licensee is engaged in the development of the EnSite diagnostic catheter and clinical workstation for use by electrophysiologists in diagnosing and mapping abnormal heart rhythms known as tachycardias.

IPSCIO Record ID: 372411

License Grant
This license is granted upon execution of the option to license and already accepted by Licensee. With Licensee exercising the option to license, Licensee is additionally granted  a non-exclusive, sublicensable license in the field for the countries Licensor is not able to fulfill Sections 3.8 or 3.9 to use any Background Patents necessary for the use and exploitation of the Catheter Technology, Peripheral Technology or Product to the extent related to the Application.
License Property
Licensor is a leading company developing, manufacturing and selling devices as well as developing treatment plans for various medical indications, such as deep brain stimulation or cardiac ablation.

Product shall mean and comprise a combination of hardware, software and workflow procedures allowing the performance of the Application or parts thereof under simultaneous MR imaging, which the Parties wish to develop under this Agreement and which is defined in more detail in Agreement. The Product shall be integrated and developed by Licensor as a medical product according to applicable local medical product regulations including, but not limited to the EU and the USA, integrating and combining the Software, MR System, Catheter Technology and Peripheral Technology. The summary describes the components and operation of an MRI-guided EP ablation system. The system uses active (signal receiving) invasive devices and special software for customized image reconstruction and display. In the prototyping phase, the software component of the system will run on a computer attached to the scanner, while for the product version, the software component of the system will run on the scanners host computer.

MR System shall mean any applicable Licensee MR system. Target MR System for the Product include the Magnetom Verio and the Magnetom Espree. Other MR System might be added after mutual agreement. The MR System is currently provided by Licensee as a medical product according to applicable local medical product regulations in several countries, including, but not limited to, the EU, Canada and the USA.

Software means software and dedicated MR sequences, which are developed by Licensee according to requirement specifications by Licensor. These specifications are defined in the Agreement. For the avoidance of doubt, Software does not include the base modules IFE and IRTTT, or any further developments or future versions of IFE or IRTTT, but only the dedicated plug in module dedicated to the workflow of the Product developed under this Agreement.

Background Patents shall mean patent applications, patents, utility models and other statutory protection with regard to MR System, Application, Catheter Technology, Peripheral Technology, Software, Integration or the Product under which one PARTY is the owner and/or has the right of determination at any time during the term of this Agreement and which are not a Development Result.

Catheter Technology shall mean and comprise the invasive medical devices (e.g. guidewire, catheters) supplied by Licensor for the use in the Product and within and in close proximity to an MR System and which are defined in this Agreement. The Catheter Technology shall be provided by Licensor as a medical product according to applicable local medical product regulations including, but not limited to, the EU and the USA.

Peripheral Technology means hardware and software required by the user to perform the Application with the Product and which is not already included in Catheter Technology or Software or MR System.

Application shall mean the treatment of cardiac arrhythmia by catheter mediated ablation under simultaneous MR imaging and catheter mediated cardiac electrophysiological mapping under simultaneous MR imaging by using the Product. In the event the width of an Application is specified through guidelines of regulatory bodies like SFDA, CE, FDA, such specification shall apply.

Field of Use
Licensee is a leading company in developing, manufacturing and selling Magnetic Resonance (“MR”) Imaging systems, which are used worldwide for diagnostics of a wide variety of medical indications. MR imaging is free of ionizing radiation and is therefore well-suited for continued supervision of treatment procedures.

The Parties wish to establish a Cooperation and Development Agreement aiming at a combination of the capabilities of Catheter Ablation and MR imaging in developing a product combination that allows performing the treatment of cardiac arrhythmias by catheter mediated ablation and catheter mediated cardiac electrophysiological mapping procedure under simultaneous MR imaging for worldwide marketing and sales.  The Parties agree that this treatment consists of a procedure with the involvement of different medical devices, including catheters and mapping technology as well as MR imaging guidance. The Parties intend to develop an MR workflow with all required components integrated into the special requirements of the MR environment.

Field shall mean treatment of cardiac arrhythmia by catheter mediated ablation under simultaneous MR imaging and catheter mediated cardiac electrophysiological mapping under simultaneous MR imaging.

IPSCIO Record ID: 257491

License Grant
The parties desire to amend and restate the relationship between the parties that currently exists by virtue of the Exclusive License Agreement dated  January 30, 1973,  to restate the grant to assigned Licensee of the sole and exclusive worldwide license for the use of said patents, patent applications, and inventions.

Licensor grants the sole and exclusive license and right to manufacture, use, sell, rent and lease or otherwise dispose of any and all devices under the Patent Rights and or any Improvements thereof throughout the United States, its territories and possessions, and in any and all foreign countries, subject to the terms and conditions set forth in this Exclusive License Agreement.

License Property
The licensed property includes Implantable Defibrillators, lead devices and other device for use with an Implantable Defibrillator.

Defibrillation is a treatment for life-threatening cardiac dysrhythmias, specifically ventricular fibrillation (VF) and non-perfusing ventricular tachycardia (VT). A defibrillator delivers a dose of electric current (often called a countershock) to the heart.

Field of Use
The field of use is Implantable Defibrillators.  This agreement pertains to the medical industry.

IPSCIO Record ID: 2663

License Grant
Seller, an individual, hereby sells, assigns, transfers and conveys to Purchaser all right, title and interest it has in and to the Patents and all inventions and discoveries described therein, including without limitation, all rights of Seller under the Assignment Agreement, and all rights of Seller to collect royalties under such Patents.
License Property
The Licensor (Seller) wishes to sell to the Licensee (Purchaser) all right, title and interest in the Patents 5,476,450. Apparatus and Method for Aspirating Intravascular, Pulmonary and Cardiac Obstructions.

IPSCIO Record ID: 1850

License Grant
The Company entered into an agreement for the license for Epidural catheters used to infuse drugs into the epidural space in the spinal column (vi) Implantable infusion ports and pumps and their attached catheters used for drug therapy and access to the vascular system (vii) Intra-aortic balloon catheters (viii) Drainage catheters used to drain chest cavities, surgical incisions, wounds and abscesses.
Field of Use
Fields of Application)
(v) Epidural catheters used to infuse drugs into the epidural space in the spinal column.
(vi) Implantable infusion ports and pumps and their attached catheters used for drug therapy and access to the vascular system.
(vii) Intra-aortic balloon catheters.
(viii) Drainage catheters used to drain chest cavities, surgical incisions, wounds and abscesses.

IPSCIO Record ID: 4807

License Grant
The Company hereby grants within the Field of Use the exclusive rights to several ultrasound technologies for use in the field of electrophysiology.
License Property
Echomark (5,076,278)  means EchoCath's proprietary catheter positioning system which is covered by the Patents.

EchoEye (5,373,845) means proprietary technology for allowing clinicians to view tissues and organs in three-dimensional real-time and provide forward looking intravascular images and guidance for ultrasound guided procedures, and covered by the Patents.

ColorMark (5,329,927) means proprietary needle and stylete positioning system which is covered by the Patents.

Field of Use
Field of Use shall include the application of the EchoMark, EchoEye and ColorMark technologies as they apply to any and all systems and products which are designed and/or manufactured for electrophysiology applications to include but not limited to mapping, ablation and internal cardioversion.  The Field of Use specifically excludes permanent pacemaker leads and permanent defibrillator leads attached to permanent implantable pulse generators.

IPSCIO Record ID: 308743

License Grant
Licensor grants to Licensee a worldwide, exclusive license to make, have made, use and sell Royalty Products.
License Property
Royalty Product means any Lead Extractor covered by a claim of an unexpired patent in the Licensed Intellectual Property or employing Licensor Confidential Information in the Licensed Intellectual Property; provided that the laser generators and other capital equipment of Licensee will not be considered Royalty Product. Lead Extractors sold for the purpose of clinical trials required for obtaining government approval to market in any country shall not be deemed Royalty Product.

Lead Extractor means a device for aiding in removal of medical devices such as pacing and defibrillation leads or catheters.

Licensed Intellectual Property means (1) All U.S. patents and patent applications owned by or licensed to, with the right to sublicense, Licensor which are now or during the term of this Agreement developed for use in the laser extraction of leads or catheters, including U.S. Patent 5,423,806 entitled 'Laser Extractor for an Implanted Object' and U.S. Patent Application 08/153,715 entitled 'Heart Synchronized Extractor for an Implanted Object'; (2) all patent rights derived from such patents and patent applications, including but not limited to foreign rights, divisionals, continuations, continuations in part, re-issues, and reexaminations; and (3) any confidential information provided to Licensee by Licensor (a) under the terms of the Agreement for Mutual Exchange of Confidential Information between Licensee and Licensor dated May 21, 1991 (the Confidentiality Agreement), (b) in written form and marked as proprietary, confidential or the like, before and during the development of Licensee products, including but not limited to the original concept drawings and information disclosures (collectively the Licensor Confidential Information).  Licensor Confidential Information shall not, however, include information which
    (i)   is or was known to Licensee prior to receipt thereof under this Agreement or the Confidentiality Agreement, as evidenced by written records;
    (ii)  is disclosed without restriction to Licensee in good faith by a third party who is in lawful possession thereof and who has the right to make such disclosure;
    (iii) is or shall have become public knowledge, by publication or otherwise, through no fault of Licensee;  
    (iv)  is discovered by Licensee completely without reference to Licensor Confidential Information; or
    (v)   is transmitted to Licensee by Licensor after Licensor received notification in writing from Licensee that Licensee did not desire to receive any further Licensor Confidential information.

U.S. Patent 5,423,806 entitled Laser Extractor for an Implanted Object
U.S. Patent Application 08/153,715 entitled Heart Synchronized Extractor for an Implanted Object

Licensor has developed technology relating to laser lead extraction and owns intellectual property related thereto.

Field of Use
The field of use is in the medical industry relating to devices for aiding in removal of medical devices such as pacing and defibrillation leads or catheters.

Licensee develops, manufactures, markets, and distributes its technology for interventional cardiovascular therapy. The Companys system is used in applications such as coronary angioplasty and the removal of pacemaker leads.

IPSCIO Record ID: 3990

License Grant
The Foundation owns the Licensable Technology as defined. The Optionee specializes in developing technology and bringing new technologies to market; and desires to investigate and conduct due diligence with respect to the commercial viability of the Licensable Technology prior to executing the License Agreement.
License Property
'Licensable Patents' shall refer to and mean US Patent Application # 60/797,433 entitled 'Intra-jugular Catheter' and any U.S. or foreign patent applications, reissues, extensions, renewals, reexaminations, certificates of invention, substitutions, divisions, continuations, and continuations-in-part thereof having the Principal Investigator as an inventor and having the same priority date as the parent applications. The Field shall mean clinical use as a catheter for insertion into the vascular system of a patient to direct fluid flow, sampling of fluids and oxygenation monitoring.
Field of Use
'Field' shall mean clinical use as a catheter for insertion into the vascular system of a patient to direct fluid flow, sampling of fluids and oxygenation monitoring.

IPSCIO Record ID: 264

License Grant
The U.S. & German Parties wish to establish a Cooperation and Development Agreement aiming at a combination of the capabilities of Catheter Ablation and MR imaging in developing a product combination that allows performing the treatment of cardiac arrhythmias by catheter mediated ablation and catheter mediated cardiac electrophysiological mapping procedure under simultaneous MR imaging for worldwide marketing and sales.
License Property
Product shall comprise a combination of hardware, software and workflow procedures allowing the performance of the application or parts thereof under simultaneous MR imaging, which the Parties wish to develop under this Agreement.

The Licensor shall perform the catheter technology development, the peripheral technology development ad the integration work and the required to create and provide the product and the Licensee shall be responsible for initiation and execution of any procedures in connection with all related regulatory requirements in the EU, Canada and the USA, both for use under clinical study regulations or for clinical use.

The Licensee shall perform the software development work, which shall be based on the specifications in the Agreement.

“CATHETER TECHNOLOGY” shall mean and comprise the invasive medical devices (e.g. guidewire, catheters).

Field of Use
The Field shall mean treatment of cardiac arrhythmia by catheter mediated ablation under simultaneous MR imaging and catheter mediated cardiac electrophysiological mapping under simultaneous MR imaging.

IPSCIO Record ID: 309973

License Grant
For the Exclusive License, the Swiss Licensor, an individual who is the Director of the Licensee, grants an exclusive transferable license under the Licensed Subject Matter to (i) make, use, sell, offer for sale and import Products, (ii) practice any method, process or procedure in connection with its exercise of the activities described in clause (i), and (iii) otherwise exploit the Licensed Subject Matter; and to have any of the foregoing performed on its behalf by a Third Party, in each case for applications in the Field throughout the Territory.
License Property
Licensor is a Swiss physician with a specialty in Internal Medicine and Cardiology, with Core competencies in Radiofrequency ablation of arrhythmias including atrial fibrillation, ventricular tachycardia etc., and Epicardial ablations.

Licensor has rights under certain patent rights relating to systems and methods for determining dipole densities on cardiac walls.  The patents are Method and Device for Determining and Presenting Surface Charge and Dipole Densities on Cardiac Walls; and, Device and Method for the Geometric Determination of Electrical Di pole Densities on the Cardiac Wall.

Dipole Density Algorithm shall mean any and all methods, devices and technologies used for an invasive (including intra cardiac) and/or non-invasive recording of the tissues electrical activity within any organ.

Product shall mean any product the manufacture, sale, offer for sale, use or importation of which would infringe a Valid Claim within the Licensed Patents in the country for which such product is intended for sale.

Field of Use
Licensee is an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, committed to advancing the field of electrophysiology.

IPSCIO Record ID: 3608

License Grant
Assignor, an individual, desires to sell, assign, transfer and convey to Assignee, its successors and assigns, Assignor's entire right, title and interest throughout the world in and to the Patent Application and patents issuing thereon to the full end of the term or terms of any said patents.
License Property
Assignor has made certain inventions relating to chimeric peptides.

Product shall mean all products, drugs, diagnostic reagents, diagnostic methods, therapeutic agents and therapeutic methods covered in whole or in part by a Valid Claim contained in any Patent.

Field of Use
Inventions and patent applications relate to the use of chimeric peptides for the treatment of Alzheimer’s disease.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.